Contribution of drug cue, priming, and stress to reinstatement of nicotine-seeking behavior in a rat model of relapse

Smoking Relapse: Causes, Prevention and Recovery

Volumn , Issue , 2010, Pages 143-163

  Liu, Xiu ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84858442220     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (81)

1. Abercrombie, E. D., Keller, R. W. Jr. & Zigmond, M. J. (1988). Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: pharmacological and behavioral studies. Neuroscience, 27, 897-904.
2. Aghajanian, G. K. & VanderMaelen, C. P. (1982). alpha 2-adrenoceptor-mediated hyperpolarization of locus coeruleus neurons: intracellular studies in vivo. Science, 215, 1394-6.
3. Andreoli, M., Tessari, M., Pilla, M., Valerio, E., Hagan, J. J. & Heidbreder, C. A. (2003). Selective antagonism at dopamine D3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior. Neuropsychopharmacology, 28, 1272-80.
4. Aubin, H. J., Bobak, A., Britton, J. R., Oncken, C., Billing, C. B. Jr., Gong, J., Williams, K. E. & Reeves, K. R. (2008). Varenicline versus transdermal nicotine patch for smoking cessation: Results from a randomised, open-label trial. Thorax.
5. Bala, M. M., Lesniak, W. & Strzeszynski, L. (2008). Efficacy of pharmacological methods used for treating tobacco dependence: meta-analysis. Pol Arch Med Wewn, 118, 20-8.
6. Balfour, D. J., Wright, A. E., Benwell, M. E. & Birrell, C. E. (2000). The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence. Behav Brain Res, 113, 73-83.
7. Bossert, J. M., Ghitza, U. E., Lu, L., Epstein, D. H. & Shaham, Y. (2005). Neurobiology of relapse to heroin and cocaine seeking: an update and clinical implications. Eur J Pharmacol, 526, 36-50.
8. Brandon, T. H., Tiffany, S. T., Obremski, K. M. & Baker, T. B. (1990). Postcessation cigarette use: the process of relapse. Addict Behav, 15, 105-14.
9. Bremner, J. D., Krystal, J. H., Southwick, S. M. & Charney, D. S. (1996a). Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse, 23, 28-38.
10. Bremner, J. D., Krystal, J. H., Southwick, S. M. & Charney, D. S. (1996b). Noradrenergic mechanisms in stress and anxiety: II. Clinical studies. Synapse, 23, 39-51.
11. Buczek, Y., Le, A. D., Stewart, J. & Shaham, Y. (1999). Stress reinstates nicotine seeking but not sucrose solution seeking in rats. Psychopharmacology (Berl), 144, 183-8.
12. Caggiula, A. R., Donny, E. C., White, A. R., Chaudhri, N., Booth, S., Gharib, M. A., Hoffman, A., Perkins, K. A. & Sved, A. F. (2001). Cue dependency of nicotine self-administration and smoking. Pharmacol Biochem Behav, 70, 515-30.
13. Charney, D. S., Heninger, G. R. & Redmond, D. E. Jr. (1983). Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine. Life Sci, 33, 19-29.
14. Chaudhri, N., Caggiula, A. R., Donny, E. C., Booth, S., Gharib, M., Craven, L., Palmatier, M. I., Liu, X. & Sved, A. F. (2007). Self-administered and noncontingent nicotine enhance reinforced operant responding in rats: impact of nicotine dose and reinforcement schedule. Psychopharmacology (Berl), 190, 353-62.
15. Chiamulera, C., Borgo, C., Falchetto, S., Valerio, E. & Tessari, M. (1996). Nicotine reinstatement of nicotine self-administration after long-term extinction. Psychopharmacology (Berl), 127, 102-7.
16. Chiamulera, C., Tedesco, V., Zangrandi, L., Giuliano, C. & Fumagalli, G. (2008). Propranolol transiently inhibits reinstatement of nicotine-seeking behaviour in rats. J Psychopharmacol, (Epub ahead of print, PMID: 18832430).
17. Chopin, P., Pellow, S. & File, S. E. (1986). The effects of yohimbine on exploratory and locomotor behaviour are attributable to its effects at noradrenaline and not at benzodiazepine receptors. Neuropharmacology, 25, 53-7.
18. Cohen, C., Perrault, G., Griebel, G. & Soubrie, P. (2005). Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716). Neuropsychopharmacology, 30, 145-55.
19. Cook, J. W., McFall, M. M., Calhoun, P. S. & Beckham, J. C. (2007). Posttraumatic stress disorder and smoking relapse: A theoretical model. J Trauma Stress, 20, 989-98.
20. Cooney, N. L., Litt, M. D., Morse, P. A., Bauer, L. O. & Gaupp, L. (1997). Alcohol cue reactivity, negative-mood reactivity, and relapse in treated alcoholic men. J Abnorm Psychol, 106, 243-50.
21. Davis, M., Redmond, D. E. Jr. & Baraban, J. M. (1979). Noradrenergic agonists and antagonists: effects on conditioned fear as measured by the potentiated startle paradigm. Psychopharmacology (Berl), 65, 111-8.
22. Donny, E. C., Chaudhri, N., Caggiula, A. R., Evans-Martin, F. F., Booth, S., Gharib, M. A., Clements, L. A. & Sved, A. F. (2003). Operant responding for a visual reinforcer in rats is enhanced by noncontingent nicotine: implications for nicotine self-administration and reinforcement. Psychopharmacology (Berl), 169, 68-76.
23. Drobes, D. J. & Tiffany, S. T. (1997). Induction of smoking urge through imaginal and in vivo procedures: physiological and self-report manifestations. J Abnorm Psychol, 106, 15-25.
24. Droungas, A., Ehrman, R. N., Childress, A. R. & O'Brien, C. P. (1995). Effect of smoking cues and cigarette availability on craving and smoking behavior. Addict Behav, 20, 657-73.
25. Epstein, D. H., Preston, K. L., Stewart, J. & Shaham, Y. (2006). Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure. Psychopharmacology (Berl), 189, 1-16.
26. Erb, S., Shaham, Y. & Stewart, J. (1996). Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period. Psychopharmacology (Berl), 128, 408-12.
27. Feltenstein, M. W. & See, R. E. (2006). Potentiation of cue-induced reinstatement of cocaine-seeking in rats by the anxiogenic drug yohimbine. Behav Brain Res, 174, 1-8.
28. Fiore, M. C., Jaen, C. R., Baker, T. B., et. al. (2008). Treating tobacco use and dependence: 2008 update. Clinical practice guideline. Rockville, MD: USDHHS.
29. Funk, D., Li, Z. & Le, A. D. (2006). Effects of environmental and pharmacological stressors on c-fos and corticotropin-releasing factor mRNA in rat brain: Relationship to the reinstatement of alcohol seeking. Neuroscience, 138, 235-43.
30. Garvey, A. J., Bliss, R. E., Hitchcock, J. L., Heinold, J. W. & Rosner, B. (1992). Predictors of smoking relapse among self-quitters: a report from the Normative Aging Study. Addict Behav, 17, 367-77.
31. Ghitza, U. E., Gray, S. M., Epstein, D. H., Rice, K. C. & Shaham, Y. (2006). The anxiogenic drug yohimbine reinstates palatable food seeking in a rat relapse model: a role of CRF1 receptors. Neuropsychopharmacology, 31, 2188-96.
32. Goldberg, S. R., Spealman, R. D. & Goldberg, D. M. (1981). Persistent behavior at high rates maintained by intravenous self-administration of nicotine. Science, 214, 573-5.
33. Gonzales, D., Rennard, S. I., Nides, M., Oncken, C., Azoulay, S., Billing, C. B., Watsky, E. J., Gong, J., Williams, K. E. & Reeves, K. R. (2006). Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial. Jama, 296, 47-55.
34. Holmberg, G. & Gershon, S. (1961). Autonomic and psychic effects of yohimbine hydrochloride. Psychopharmacologia, 2, 93-106.
35. Jorenby, D. E., Hays, J. T., Rigotti, N. A., Azoulay, S., Watsky, E. J., Williams, K. E., Billing, C. B., Gong, J. & Reeves, K. R. (2006). Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. Jama, 296, 56-63.
36. Juliano, L. M., Donny, E. C., Houtsmuller, E. J. & Stitzer, M. L. (2006). Experimental evidence for a causal relationship between smoking lapse and relapse. J Abnorm Psychol, 115, 166-73.
37. Kenford, S. L., Fiore, M. C., Jorenby, D. E., Smith, S. S., Wetter, D. & Baker, T. B. (1994). Predicting smoking cessation. Who will quit with and without the nicotine patch. JAMA, 271, 589-94.
38. Lang, W. J. & Gershon, S. (1963). Effects of psychoactive drugs on yohimbine induced responses in conscious dogs. A proposed screening procedure for anti-anxiety agents. Arch Int Pharmacodyn Ther, 142, 457-72.
39. Lazev, A. B., Herzog, T. A. & Brandon, T. H. (1999). Classical conditions of environmental cues to cigarette smoking. Exp Clin Psychopharmacol, 7, 56-63.
40. Le, A. & Shaham, Y. (2002). Neurobiology of relapse to alcohol in rats. Pharmacol Ther, 94, 137-56.
41. Le, A. D., Harding, S., Juzytsch, W., Funk, D. & Shaham, Y. (2005). Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats. Psychopharmacology (Berl), 179, 366-73.
42. Lee, B., Tiefenbacher, S., Platt, D. M. & Spealman, R. D. (2004). Pharmacological blockade of alpha2-adrenoceptors induces reinstatement of cocaine-seeking behavior in squirrel monkeys. Neuropsychopharmacology, 29, 686-93.
43. LeSage, M. G., Burroughs, D., Dufek, M., Keyler, D. E. & Pentel, P. R. (2004). Reinstatement of nicotine self-administration in rats by presentation of nicotine-paired stimuli, but not nicotine priming. Pharmacol Biochem Behav, 79, 507-13.
44. Liu, X., Caggiula, A. R., Palmatier, M. I., Donny, E. C. & Sved, A. F. (2008). Cue-induced reinstatement of nicotine-seeking behavior in rats: effect of bupropion, persistence over repeated tests, and its dependence on training dose. Psychopharmacology (Berl), 196, 365-75.
45. Liu, X., Caggiula, A. R., Yee, S. K., Nobuta, H., Poland, R. E. & Pechnick, R. N. (2006). Reinstatement of nicotine-seeking behavior by drug-associated stimuli after extinction in rats. Psychopharmacology (Berl), 184, 417-25.
46. Liu, X., Caggiula, A. R., Yee, S. K., Nobuta, H., Sved, A. F., Pechnick, R. N. & Poland, R. E. (2007a). Mecamylamine attenuates cue-induced reinstatement of nicotine-seeking behavior in rats. Neuropsychopharmacology, 32, 710-8.
47. Liu, X., Palmatier, M. I., Caggiula, A. R., Donny, E. C. & Sved, A. F. (2007b). Reinforcement enhancing effect of nicotine and its attenuation by nicotinic antagonists in rats. Psychopharmacology (Berl), 194, 463-73.
48. Liu, X., Palmatier, M. I., Caggiula, A. R., Sved, A. F., Donny, E. C., Gharib, M. & Booth, S. (2009). Naltrexone attenuation of conditioned but not primary reinforcement of nicotine in rats. Psychopharmacology (Berl), 202, 589-98.
49. Liu, X. & Weiss, F. (2002). Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J Neurosci, 22, 7856-61.
50. Lu, L., Shepard, J. D., Hall, F. S. & Shaham, Y. (2003). Effect of environmental stressors on opiate and psychostimulant reinforcement, reinstatement and discrimination in rats: a review. Neurosci Biobehav Rev, 27, 457-91.
51. Mackintosh, N. J. (1974). The psychology of animal learning. Academic, New York.
52. Marlatt, G. A., Curry, S. & Gordon, J. R. (1988). A longitudinal analysis of unaided smoking cessation. J Consult Clin Psychol, 56, 715-20.
53. McDermut, W. & Haaga, D. A. (1998). Effect of stage of change on cue reactivity in continuing smokers. Exp Clin Psychopharmacol, 6, 316-24.
54. McKay, J. R. (1999). Studies of factors in relapse to alcohol, drug and nicotine use: a critical review of methodologies and findings. J Stud Alcohol, 60, 566-76.
55. Nair, S. G., Gray, S. M. & Ghitza, U. E. (2006). Role of food type in yohimbine-and pellet-priming-induced reinstatement of food seeking. Physiol Behav, 88, 559-66.
56. Nides, M. A., Rakos, R. F., Gonzales, D., Murray, R. P., Tashkin, D. P., Bjornson-Benson, W. M., Lindgren, P. & Connett, J. E. (1995). Predictors of initial smoking cessation and relapse through the first 2 years of the Lung Health Study. J Consult Clin Psychol, 63, 60-9.
57. Norregaard, J., Tonnesen, P. & Petersen, L. (1993). Predictors and reasons for relapse in smoking cessation with nicotine and placebo patches. Prev Med, 22, 261-71.
58. O'Brien, C. P., Childress, A. R., Ehrman, R. & Robbins, S. J. (1998). Conditioning factors in drug abuse: Can they explain compulsion? J. Psychopharmacol., 12, 15-22.
59. Oncken, C., Gonzales, D., Nides, M., Rennard, S., Watsky, E., Billing, C. B., Anziano, R. & Reeves, K. (2006). Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Arch Intern Med, 166, 1571-7.
60. Palmatier, M. I., Evans-Martin, F. F., Hoffman, A., Caggiula, A. R., Chaudhri, N., Donny, E. C., Liu, X., Booth, S., Gharib, M., Craven, L. & Sved, A. F. (2006). Dissociating the primary reinforcing and reinforcement-enhancing effects of nicotine using a rat self-administration paradigm with concurrently available drug and environmental reinforcers. Psychopharmacology (Berl), 184, 391-400.
61. Paterson NE, Froestl W, Markou A (2005). Repeated administration of the GABAB receptor agonist CGP44532 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine-seeking in rats. Neuropsychopharmacology 30, 119-28.
62. Palmatier, M. I., Liu, X., Matteson, G. L., Donny, E. C., Caggiula, A. R. & Sved, A. F. (2007). Conditioned reinforcement in rats established with self-administered nicotine and enhanced by noncontingent nicotine. Psychopharmacology (Berl), 195, 235-43.
63. Perkins, K. A., Grobe, J. E., Fonte, C., Goettler, J., Caggiula, A. R., Reynolds, W. A., Stiller, R. L., Scierka, A. & Jacob, R. G. (1994). Chronic and acute tolerance to subjective, behavioral and cardiovascular effects of nicotine in humans. J Pharmacol Exp Ther, 270, 628-38.
64. Rose, J. E. & Levin, E. D. (1991). Inter-relationships between conditioned and primary reinforcement in the maintenance of cigarette smoking. Br J Addict, 86, 605-9.
65. Schroeder, B. E., Schiltz, C. A. & Kelley, A. E. (2003). Neural activation profile elicited by cues associated with the anxiogenic drug yohimbine differs from that observed for reward-paired cues. Neuropsychopharmacology, 28, 14-21.
66. Shaham, Y., Adamson, L. K., Grocki, S. & Corrigall, W. A. (1997). Reinstatement and spontaneous recovery of nicotine seeking in rats. Psychopharmacology (Berl), 130, 396-403.
67. Shaham, Y., Erb, S. & Stewart, J. (2000). Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res Brain Res Rev, 33, 13-33.
68. Shaham, Y., Shalev, U., Lu, L., De Wit, H. & Stewart, J. (2003). The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl), 168, 3-20.
69. Shepard, J. D., Bossert, J. M., Liu, S. Y. & Shaham, Y. (2004). The anxiogenic drug yohimbine reinstates methamphetamine seeking in a rat model of drug relapse. Biol Psychiatry, 55, 1082-9.
70. Shiffman, S., Ferguson, S. G. & Gwaltney, C. J. (2006). Immediate hedonic response to smoking lapses: relationship to smoking relapse, and effects of nicotine replacement therapy. Psychopharmacology (Berl), 184, 608-18.
71. Shiffman, S., Paty, J. A., Gnys, M., Kassel, J. A. & Hickcox, M. (1996). First lapses to smoking: within-subjects analysis of real-time reports. J Consult Clin Psychol, 64, 366-79.
72. Shiffman, S. & Waters, A. J. (2004). Negative affect and smoking lapses: a prospective analysis. J Consult Clin Psychol 72, 192-201.
73. Shoaib M (2008). The cannabinoid antagonist AM251 attenuates nicotine self-administration and nicotine-seeking behaviour in rats. Neuropharmacology, 54, 438-44.
74. Shram, M. J., Funk, D., Li, Z. & Le, A. D. (2008). Nicotine self-administration, extinction responding and reinstatement in adolescent and adult male rats: evidence against a biological vulnerability to nicotine addiction during adolescence. Neuropsychopharmacology, 33, 739-48.
75. Sinha, R. (2001). How does stress increase risk of drug abuse and relapse? Psychopharmacology (Berl), 158, 343-59.
76. Stewart, J. (2000). Pathways to relapse: the neurobiology of drug-and stress-induced relapse to drug-taking. J Psychiatry Neurosci, 25, 125-36.
77. Swan, G. E., Denk, C. E., Parker, S. D., Carmelli, D., Furze, C. T. & Rosenman, R. H. (1988). Risk factors for late relapse in male and female ex-smokers. Addict Behav, 13, 253-66.
78. Uhde, T. W., Boulenger, J. P., Post, R. M., Siever, L. J., Vittone, B. J., Jimerson, D. C. & Roy-Byrne, P. P. (1984). Fear and anxiety: relationship to noradrenergic function. Psychopathology, 17 Suppl 3, 8-23.
79. Zarrindast, M. R., Homayoun, H., Babaie, A., Etminani, A. & Gharib, B. (2000). Involvement of adrenergic and cholinergic systems in nicotine-induced anxiogenesis in mice. Eur J Pharmacol, 407, 145-58.
80. Zhou, X., Nonnemaker, J., Sherrill, B., Gilsenan, A. W., Coste, F. & West, R. (2009). Attempts to quit smoking and relapse: factors associated with success or failure from the ATTEMPT cohort study. Addict Behav, 34, 365-73.
81. Zislis, G., Desai, T. V., Prado, M., Shah, H. P. & Bruijnzeel, A. W. (2007). Effects of the CRF receptor antagonist D-Phe CRF(12-41) and the alpha2-adrenergic receptor agonist clonidine on stress-induced reinstatement of nicotine-seeking behavior in rats. Neuropharmacology, 53, 958-66.